Our group also showed that BOLCs (RUNX2- RANKL double positive breast cancer cells) significantly increase in estrogen receptor (ER) positive breast cancers rather than human epidermal growth factor receptor-2 (HER2) positive ones. The gene discussed is TNFSF11; the disease is breast cancer.